Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic cisplatin sustained-release implants for advanced esophageal cancer after chemo-radiotherapy failure
ChiCTR-IIR-16008787Phase 3Recruiting
- Sponsor
- Xijing Hospital
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of cisplatin in esophageal cancer (2 arms), sponsored by Xijing Hospital. Primary endpoints: Overall survival and Swallowing difficulty control. Started Jul 2016; status: recruiting.
02
Drugs
cisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR-IIR-16008787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008787.